CDRH Explains New Process For Guidance Development
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is piloting a new standard operating procedure for its staff aimed at improving guidance-document development.
You may also be interested in...
FDA Unveils Plan To Boost Transparency To Industry
Included in a new list of things FDA will do to improve its communications with manufacturers is a vow to respond more quickly to industry questions.
Shuren's CDRH Sets Ambitious 2010 Agenda: 510(k), PMA Changes Planned
CDRH launched an ambitious 2010 agenda Jan. 20 that includes changes to the 510(k) and PMA pre-market programs by this fall, harmonized international inspection activities by 2011 and unique device identifiers by 2013
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.